Groningen- Start of the 1st Dutch trial site

On 8 April  2026, the University Medical Center Groningen became officially the first active trial site of the STOP-PKD Study in Netherlands.

Prof. Dr. Ron T. Gansevoort´s team cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Groningen to obtain detailed information about the trial and potential participation.

Phone: +31 50-3611621 / +31 06 256 48 951

Email:  cystenieren@umcg.nl